Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Accelerate Diagnostics, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 84 | +10 |
| Shares | 18.7M | 65.9K | 27.1M | +8.43M (+45.1%) |
| Value | $18.6M | $65.4K | $41.2M | +$22.6M (+122.1%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,737,211 | $2.64M | 0.03% |
| AWM Investment Company, Inc. | 491,100 | $746.0K | 0.11% |
| 1492 Capital Management LLC | 449,746 | $684.0K | 0.49% |
| Driehaus Capital Management LLC | 300,000 | $456.0K | 0.01% |
| Two Sigma Investments, LP | 216,738 | $329.0K | 0.00% |
| Calamos Advisors LLC | 174,487 | $266.0K | 0.00% |
| Russell Investments Group, Ltd. | 136,584 | $207.0K | 0.00% |
| Gsa Capital Partners LLP | 120,696 | $183.0K | 0.02% |
| Jacobs Levy Equity Management, Inc | 106,976 | $163.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 70,929 | $108.0K | 0.00% |
| Group One Trading, L.P. | 38,155 | $58.0K | 0.00% |
| Charles Schwab Investment Management Inc | 30,507 | $47.0K | 0.00% |
| XTX Topco Ltd | 31,176 | $47.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 18,768 | $29.0K | 0.00% |
| Virtu Financial LLC | 18,310 | $28.0K | 0.00% |
| Raymond James & Associates | 17,499 | $27.0K | 0.00% |
| Two Sigma Securities, LLC | 15,128 | $23.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 14,524 | $22.0K | 0.00% |
| Covington Capital Management | 175 | $0 | 0.00% |
Sold out (9)
Institutions that held Accelerate Diagnostics, Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 132,300 | $131.0K |
| HRT Financial LP | 115,592 | $114.0K |
| Acadian Asset Management LLC | 38,229 | $38.0K |
| AQR Capital Management LLC | 28,097 | $28.0K |
| Watchman Group, Inc. | 20,000 | $20.0K |
| Man Group plc | – | $10.0K |
| Venture Visionary Partners LLC | 250 | $248 |
| New York State Common Retirement Fund | 273 | $0 |
| Citigroup Inc | 492 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Accelerate Diagnostics, Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Chartist Inc | 65,865 | $65.4K |